Funding for this research was provided by:
Medical Research Council (MR/M50197/1)
Agence Nationale de la Recherche (MicrobiAutism)
EraNet NEURON (291840)
Région Centre Val-de-Loire (ARD2020 Biomédicaments GPCRAb)
Received: 29 January 2021
Accepted: 27 May 2021
First Online: 8 July 2021
: Animal housing and experimentation were conducted in facilities certified by regional authorities (Direction Départementale de Protection des Populations des Alpes-Maritimes, accreditation #EC-06-152-5). The procedures involved in this study were approved by the local ethics committee for animal experimentation (Ciepal-Azur) and the Ministère de l’Enseignement Supérieur et de la Recherche, in agreement with the European Communities Council Directive (2010/63EU) for animal experiments.
: Not applicable.
: The authors declare that they have no competing interests.